Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases

M Jäättelä1, D Wissing, K Kokholm

  • 1Apoptosis Laboratory, Institute of Cancer Biology, Danish Cancer Society, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.

The EMBO Journal
|November 3, 1998
PubMed

Insights

Heat shock protein 70 (Hsp70) inhibits apoptosis by blocking late-stage cell death events. This major heat shock protein offers a novel therapeutic target for preventing programmed cell death.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Apoptosis, or programmed cell death, is a critical cellular process.
  • Heat shock proteins (HSPs) are known to play roles in cellular stress response and survival.
  • Hsp70 is a major heat shock protein implicated in inhibiting apoptosis.

Purpose of the Study:

  • To investigate the mechanism by which Hsp70 inhibits apoptosis.
  • To determine the specific stage of the apoptotic pathway affected by Hsp70.
  • To evaluate Hsp70 as a potential therapeutic target for modulating cell death.

Main Methods:

  • Generation of tumor cell lines with varying Hsp70 expression levels.
  • Treatment of cell lines with apoptotic stimuli (TNF, staurosporine, doxorubicin).
  • Analysis of apoptotic markers including caspase activation, mitochondrial potential, and nuclear morphology.

Main Results:

  • Hsp70 expression levels correlated with cell survival following apoptotic stimuli.
  • Hsp70-expressing cells exhibited early apoptotic events similar to low Hsp70 cells.
  • Hsp70 specifically inhibited late, caspase-dependent apoptotic events and protected against caspase-3-induced cell death.

Conclusions:

  • Hsp70 acts as an anti-apoptotic factor by interfering with late-stage apoptotic signaling.
  • Hsp70's mechanism of action occurs later in the apoptotic pathway than other known inhibitors.
  • Hsp70 represents a promising therapeutic target for controlling apoptosis in various conditions.

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...